The Dubai Nuclear Medicine Conference reveals a new technology to diagnose Alzheimer’s accurately up to 95%

The Fifth UAE International International Conference, in cooperation with the Arab Association for Nuclear Medicine, held at Mohammed Bin Rashid University of Medicine and Health Sciences, revealed a new medical technology that enables Alzheimer’s disease before the appearance of clinical symptoms of 90 to 95%, by tracking the accumulation of certain proteins in the brain using hybrid cameras based on molecular imaging techniques, which is considered a qualitative medical achievement for the first time in The UAE, promotes opportunities for early intervention and improving the quality of patients’ life.

The conference, continuing for two days, with wide participation of more than 300 specialists from inside and outside the country, and 35 international lectures and experts in the fields of nuclear medicine and radiotherapy, the latest findings of science in diagnosing and treating tumors using molecular imaging and molecular radiotherapy, as well as reviewing international best practices and discussing the results of modern treatments according to the latest medical protocols.

“The conference brings together a group of scientists and experts from different parts of the world, to discuss modern innovations that contribute to improving the quality of patient care, especially in the areas of tumors and thyroid gland.

She added that the conference aims to enhance regional and international cooperation, and to open new horizons for scientific research and professional development, in addition to highlighting the extensive capabilities of nuclear medicine in improving patients ’life, through a deeper understanding of advanced technologies and clinical applications, noting that this year the conference focuses on nuclear medicine applications in the treatment of tumors, including brain and thyroid diseases, along with the diagnosis and treatment of cancer using molecular imaging and treatment With radioactive substances, especially prostate and pituitary cancer.

International praise of the Emirates experience

For her part, the head of the Department of Nuclear Medicine and Diagnostic Radiology at the International Atomic Energy Agency, Dr. Diana Bez, stressed that nuclear medicine is witnessing an accelerated growth in the region, noting the importance of the conference in promoting continuous education and transferring knowledge.

She praised the experience of the UAE, saying: “What we are witnessing in the Emirates, especially in Dubai, is a advanced model in the use of the latest technologies and treatment applications, supported by highly equipped medical competencies, which makes the state on a clear path towards sustainable expansion in nuclear medicine services, and confirmed the commitment of the International Atomic Energy Agency to continue its support for international cooperation in this field, with the aim of developing the specialization and expanding the scope of the benefit of patients from these vital services.

The President of the Asian and Al -Aqnussian Nuclear Medicine, Dr. Akram Al -Ibrahim, said that the conference embodies the great development in nuclear medicine, especially in the field of careful personal medicine, by accurately directing treatments towards cancer cells without affecting healthy tissues, thanks to the advanced molecular diagnosis.

A first consultant in radiology and nuclear medicine from the Kingdom of Bahrain, Dr. Abdul Hamid Al -Awadi, stressed the importance of expanding the scope of nuclear medicine in the treatment of multiple diseases, saying, “Previously, nuclear medicine was used in a simple scope, but today it is employed in the treatment of complex diseases that include the brain, liver, kidneys and cancers, which indicates the rapid expansion of this vital specialization.